· Regulation · Regulation Desk
Reporting by CBS News and NPR found the committee was reshaped before the July vote, with new members holding disclosed peptide-industry ties. FDA staff had recommended against all seven substances.
This brief is part of the Novusyn Research news desk. We track peptide clinical readouts, regulatory actions, and pharma developments in neutral, evidence-led language for scientifically literate readers.
For related context, see the full news desk, clinical trials tracker, regulation tracker, compound directory, and guides library.